Loading…
The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review
Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (P...
Saved in:
Published in: | Drug design, development and therapy development and therapy, 2020-01, Vol.14, p.1749-1755 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23 |
---|---|
cites | cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23 |
container_end_page | 1755 |
container_issue | |
container_start_page | 1749 |
container_title | Drug design, development and therapy |
container_volume | 14 |
creator | Mercuri, S R Vollono, L Paolino, G |
description | Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo.
We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo.
Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo".
We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects.
PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo. |
doi_str_mv | 10.2147/DDDT.S239912 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A626928685</galeid><doaj_id>oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815</doaj_id><sourcerecordid>A626928685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</originalsourceid><addsrcrecordid>eNptkk1rGzEQhpfS0qRpbz2XhUJJoXYl7a5W20PBxP0IBGocp1ehj5GtoF0lkpzSf19t7QYbig4ajZ73RaOZoniN0ZTguv04n89X02tSdR0mT4pTjNt2whjDTw_ik-JFjLcI0YoS9Lw4qUhdI4zQabFebaC8iWC2boAYS2_KhRMJHKTJ0qrNeIq9KM8Xy8X70vhQpixYBRCphyGN_E-brLNr_6m8Tlk5pkZmFlIpBl0u4cHCr5fFMyNchFf7_ay4-fpldfF9cvXj2-XF7GqimpqlCZatJhSpyhiiMUisiMQNbjoN0LYgKsZyoBhWWKO2kdhQaqhiSFOGkSHVWXG589Ve3PK7YHsRfnMvLP-b8GHNRUhWOeCNboBI1kghdS21llJoSkkHNWWa4SZ7fd553W1lD1rleoNwR6bHN4Pd8LV_4C3BFaOjwfneIPj7LcTEexsVOCcG8NvISZ07gprck4y-3aFrkZ9mB-OzoxpxPqOEdoRRNhpO_0PlpaG3yg9gbM4fCd4dCDYgXNpE77bJ-iEegx92oAo-xgDmsUyM-DhnfJwzvp-zjL85_JpH-N9gVX8AnSLL2w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406305620</pqid></control><display><type>article</type><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor & Francis Open Access</source><source>PubMed Central</source><creator>Mercuri, S R ; Vollono, L ; Paolino, G</creator><creatorcontrib>Mercuri, S R ; Vollono, L ; Paolino, G</creatorcontrib><description>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo.
We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo.
Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo".
We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects.
PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</description><identifier>ISSN: 1177-8881</identifier><identifier>EISSN: 1177-8881</identifier><identifier>DOI: 10.2147/DDDT.S239912</identifier><identifier>PMID: 32440100</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Care and treatment ; Dermatologic agents ; Fibrin ; Humans ; Medical research ; Platelet-Rich Plasma ; platlet rich plasma ; prp ; Review ; Skin ; Skin diseases ; treatment ; vitiligo ; Vitiligo - therapy</subject><ispartof>Drug design, development and therapy, 2020-01, Vol.14, p.1749-1755</ispartof><rights>2020 Mercuri et al.</rights><rights>COPYRIGHT 2020 Dove Medical Press Limited</rights><rights>2020 Mercuri et al. 2020 Mercuri et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</citedby><cites>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</cites><orcidid>0000-0001-8858-9531 ; 0000-0002-3032-2217</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213865/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213865/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32440100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mercuri, S R</creatorcontrib><creatorcontrib>Vollono, L</creatorcontrib><creatorcontrib>Paolino, G</creatorcontrib><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><title>Drug design, development and therapy</title><addtitle>Drug Des Devel Ther</addtitle><description>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo.
We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo.
Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo".
We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects.
PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</description><subject>Care and treatment</subject><subject>Dermatologic agents</subject><subject>Fibrin</subject><subject>Humans</subject><subject>Medical research</subject><subject>Platelet-Rich Plasma</subject><subject>platlet rich plasma</subject><subject>prp</subject><subject>Review</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>treatment</subject><subject>vitiligo</subject><subject>Vitiligo - therapy</subject><issn>1177-8881</issn><issn>1177-8881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkk1rGzEQhpfS0qRpbz2XhUJJoXYl7a5W20PBxP0IBGocp1ehj5GtoF0lkpzSf19t7QYbig4ajZ73RaOZoniN0ZTguv04n89X02tSdR0mT4pTjNt2whjDTw_ik-JFjLcI0YoS9Lw4qUhdI4zQabFebaC8iWC2boAYS2_KhRMJHKTJ0qrNeIq9KM8Xy8X70vhQpixYBRCphyGN_E-brLNr_6m8Tlk5pkZmFlIpBl0u4cHCr5fFMyNchFf7_ay4-fpldfF9cvXj2-XF7GqimpqlCZatJhSpyhiiMUisiMQNbjoN0LYgKsZyoBhWWKO2kdhQaqhiSFOGkSHVWXG589Ve3PK7YHsRfnMvLP-b8GHNRUhWOeCNboBI1kghdS21llJoSkkHNWWa4SZ7fd553W1lD1rleoNwR6bHN4Pd8LV_4C3BFaOjwfneIPj7LcTEexsVOCcG8NvISZ07gprck4y-3aFrkZ9mB-OzoxpxPqOEdoRRNhpO_0PlpaG3yg9gbM4fCd4dCDYgXNpE77bJ-iEegx92oAo-xgDmsUyM-DhnfJwzvp-zjL85_JpH-N9gVX8AnSLL2w</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Mercuri, S R</creator><creator>Vollono, L</creator><creator>Paolino, G</creator><general>Dove Medical Press Limited</general><general>Dove</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8858-9531</orcidid><orcidid>https://orcid.org/0000-0002-3032-2217</orcidid></search><sort><creationdate>20200101</creationdate><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><author>Mercuri, S R ; Vollono, L ; Paolino, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Care and treatment</topic><topic>Dermatologic agents</topic><topic>Fibrin</topic><topic>Humans</topic><topic>Medical research</topic><topic>Platelet-Rich Plasma</topic><topic>platlet rich plasma</topic><topic>prp</topic><topic>Review</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>treatment</topic><topic>vitiligo</topic><topic>Vitiligo - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercuri, S R</creatorcontrib><creatorcontrib>Vollono, L</creatorcontrib><creatorcontrib>Paolino, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drug design, development and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercuri, S R</au><au>Vollono, L</au><au>Paolino, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</atitle><jtitle>Drug design, development and therapy</jtitle><addtitle>Drug Des Devel Ther</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>14</volume><spage>1749</spage><epage>1755</epage><pages>1749-1755</pages><issn>1177-8881</issn><eissn>1177-8881</eissn><abstract>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo.
We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo.
Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo".
We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects.
PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>32440100</pmid><doi>10.2147/DDDT.S239912</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-8858-9531</orcidid><orcidid>https://orcid.org/0000-0002-3032-2217</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1177-8881 |
ispartof | Drug design, development and therapy, 2020-01, Vol.14, p.1749-1755 |
issn | 1177-8881 1177-8881 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Open Access; PubMed Central |
subjects | Care and treatment Dermatologic agents Fibrin Humans Medical research Platelet-Rich Plasma platlet rich plasma prp Review Skin Skin diseases treatment vitiligo Vitiligo - therapy |
title | The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A12%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Usefulness%20of%20Platelet-Rich%20Plasma%20(PRP)%20for%20the%20Treatment%20of%20Vitiligo:%20State%20of%20the%20Art%20and%20Review&rft.jtitle=Drug%20design,%20development%20and%20therapy&rft.au=Mercuri,%20S%20R&rft.date=2020-01-01&rft.volume=14&rft.spage=1749&rft.epage=1755&rft.pages=1749-1755&rft.issn=1177-8881&rft.eissn=1177-8881&rft_id=info:doi/10.2147/DDDT.S239912&rft_dat=%3Cgale_doaj_%3EA626928685%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406305620&rft_id=info:pmid/32440100&rft_galeid=A626928685&rfr_iscdi=true |